Inside EU Health Inside EU Health: EU/Africa; clinical trials; JCA; French pharma; Russia; climate and health; Nobel Prize Inside EU Health: EU/Africa; clinical trials; French pharma welcomes pricing agreement; EU monitoring of pneumonia death in Irkutsk; climate and health pledge; ERC-funded scientist among winners of 2026 Nobel Prize in Medicine
Inside EU Health Inside EU Health: €5 billion for health emergencies; beating cancer; EMA; screening; first responders MEPs push for €5 billion for health emergencies; beating cancer; health informal; EMA sets out process to appoint next Executive Director; cardiovascular screening framework; cross-border communication system to strengthen emergency health response
Inside EU Health Inside EU Health: European pharma chiefs call for action; EU cloud and AI rules; data protection; US ups pressure on Germany; sport Nine pharma chiefs urge action; EU Cloud and AI Rules must not create barriers for European pharma; call for patient data safeguards in Digital Omnibus; US ups pressure on Germany; more Europeans turn to exercise for physical and mental health
Inside EU Health Inside EU Health: Biosimilars; EMA; cardiovascular; healthcare workforce; equal pay; nicotine pouches; EU KIDS Act Biosimilar uptake; EMA recommendations; parliament’s cardiovascular report; ‘Fair Labour Mobility’ package; gender pay gap; Germany debates nicotine pouches: EU Kids Act targets social media’s impact on children’s mental health
Inside EU Health Inside EU Health: Spanish proposal on access; biosimilars; illicit tobacco trade; anaphylaxis; preparedness; radioisotopes; insulin Spain pushes EU to use its purchasing power on innovative medicines; better deal for biosimilars; auditors on illicit tobacco trade; anaphylaxis preparedness; crisis procurement handbook; EU backs next-generation mRNA nasal sprays; strategy on radioisotopes; EU approves €400m aid for insulin supply
Inside EU Health Inside EU Health: Organ transplantation; wastewater; cross-border health; childhood cancer; next WHO DG Organ transplant technology; Advocate General questions the basis of EU wastewater rules; EU solidarity fund to improve access to cross-border healthcare; MEPs pressed to close gaps in childhood cancer treatment; Hans Kluge next WHO DG?
Inside EU Health Inside EU Health: Spain to propose alternative to SPC; clinical trials transparency; AI Spain to propose early procurement as an alternative to SPC Extension; European health NGOs push for full publication of clinical trial results; WHO/Europe urges faster development of AI governance
Inside EU Health Inside EU Health: Medical devices; Irish Presidency; CMA Schenk pushes for simpler EU medical devices rules; Carroll MacNeill tells MEPs she’s putting competitiveness and access at heart of Irish Presidency; MEPs give Critical Medicines Act final committee green light ahead of November plenary
Inside EU Health Inside EU Health: Online child safety; MEPS on US visit; hospital beds data; EU/UK cooperation on illegal drugs EU weighs age-13 limit for 'social media plus'; US CDC officials 'ashamed' of US retreat from global health, MEP says; number of hospital beds per 100,000 people continues to decline; UK and EU drugs agency sign pact to cooperate on illicit drugs
Inside EU Health Inside EU Health: Preparedness; Sanofi peace offering; two JCAs; infringements Preparedness under long-term budget; Sanofi offers concessions; two joint clinical assessments for lung cancer treatments; Romania late payments to pharmacies; nurses' recognition; six EU nations face pressure after missing asbestos safety deadline
Inside EU Health Inside EU Health: Cancer inequalities; fast-track for pancreatic cancer treatment; counterfeit condoms WHO warns of widening cancer survival gap as cases set to soar to 35 million by 2050; EMA to fast track promising pancreatic cancer treatment; 200,000 counterfeit condoms discovered by EU anti-fraud office
Inside EU Health Inside EU Health: Tobacco games Commission consultation; pharma push back on PABS; Danes pilot real-world data to assess cancer drugs Dutch investigation finds that Philip Morris is gaming tobacco consultation; Pharmaceutical companies caution against tougher obligations in PABS talks; Denmark turns to real-world data to assess cancer drugs
Inside EU Health Inside EU Health: MFN; €84.8 million health innovation call; medical countermeasures; UK/US deal could cost more lives than COVID Can the EU resist US pressure on medicine prices? €84.8m launches call to support healthy ageing, reduced animal testing and early-stage innovation; EU seeks partners to shape new medical countermeasures preparedness network; UK deal with US could cost more lives than COVID
Inside EU Health Inside EU Health: Women’s health; digital; Ebola; Marburg; hantavirus 'Now is really the time!' for women's health, says Cooke; Macron and WHO chief back stronger safeguards for children online; Ebola outbreak expands and WHO condemns attacks on health facilities; WHO declares cruise ship hantavirus outbreak over
Inside EU Health Inside EU Health: WHO/Europe on heatwave; Salmonella; pharma leads high-tech production WHO Europe says current heatwave is ‘dress rehearsal’ for hotter summers; Salmonella cases in 13 EU countries linked to instant noodles; Pharmaceuticals lead the EU’s high-tech production in 2024
Inside EU Health Inside EU Health: Biotech Act; Critical Medicines Act; preparedness MEPs supportive of draft Biotech report, but divisions over incentives remain; Critical Medicines Act text finalised; preparedness should include all viral families, say international organisations
Inside EU Health Inside EU Health: Heat resilience; EMA recommendations; Sanofi disparagement Europe’s deadly heatwave highlights growing climate threat to health; EMA recommends three new medicines and an orphan treatment for rare Rett Syndrome; Commission opens disparagement investigation into Sanofi
Inside EU Health Inside EU Health: Cardiovascular; Ebola; North Macedonia joins EU4Health MEPs adopt cardiovascular strategy, prioritising early detection and risk reduction; France reports first case of Ebola and WHO launches its first trials; North Macedonia joins the EU4Health programme
Inside EU Health Inside EU Health: Cancer-causing chemicals; patient groups want HTA improvements; benefits of investing in innovative medicines EU agrees tougher protections against cancer-causing chemicals; patient groups welcome progress on EU HTA while calling for further improvements; every €1 invested in innovative medicines returns €5.67 in benefits, claims EFPIA
Inside EU Health Inside EU Health: Public benefit for EU research; US trade challenge to Germany; SoHo 50 organisations call for public benefit from publicly funded medicines research; Lange warns ‘Section 301’ investigation threatens Turnberry trade deal; ECDC unveils harmonised screening standards for HBV and HCV screening
Inside EU Health Inside EU Health: Parliament supports wastewater revision; eHealth Commission defends Urban Wastewater Directive against EPP-ECR challenge; EU narrows gap to 2030 health data target by 4% points
Inside EU Health Inside EU Health: Trump tariff threat; tobacco taxation; G7 cancer commitment; Ebola Trump continues to threaten pharma tariffs; Parliament rejects tobacco taxation report; EU backs coordinated Ebola response and commits further €31.5 million; G7 leaders renew commitment to fight cancer
Inside EU Health Inside EU Health: MFN; wastewater treatment; medical devices; social media Implications of MFN note before summer; Várhelyi reassures ministers on Urban Wastewater Treatment implementation; on medical devices divisions persist over governance; special panel on online child safety will present its final report on 13 July
Inside EU Health Inside EU Health: EPSCO - Biotech Act, Medical Devices and Urban wastewater treatment; heat action plans; vaccines EU health ministers to discuss wastewater rules, the Biotech Act and medical devices; Europe lost 200,000 people to heat in 4 years; MEPs and health groups call for stronger vaccine R&D funding in next EU budget
Inside EU Health Inside EU Health: Co-ordinated pricing and reimbursement; Biotech Act SPC; COVID-19 contracts Beneluxa Initiative calls for pricing and reimbursement coordination; EFPIA argues that the Biotech Act 12-month extension to SPC is too narrow ; AG recommends dismissing Commission appeal on COVID-19 contract access
